Citations 1
A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
Voorhees, Peter M. , Hurd, David D., Rodriguez, Cesar , Korde, Neha , Safah, Hana, Bueno, Orlando F. , Pumford, Neil R., Rosenberg, Tanya S, Pothacamury, Rajvineeth Kumar, Polepally, Akshanth R. , Talati, Chetasi, Vij, Ravi , Kumar, Shaji , D’Souza, Anita , Weisel, Katja C , Teipel, Raphael , Chung, Alfred , Tuchman, Sascha Alexander , Pumford, Neil, Ross, Jeremy A. , Lee, Shane , Jin, Ziyi , Talati, Chetasi
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4401-4404
